{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:16:50Z","timestamp":1779243410191,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T00:00:00Z","timestamp":1250121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/gene.2009.61","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T08:57:21Z","timestamp":1250153841000},"page":"1-10","source":"Crossref","is-referenced-by-count":29,"title":["A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis"],"prefix":"10.1038","volume":"11","author":[{"given":"J M","family":"Heckmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Uwimpuhwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V B","family":"Bajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,13]]},"reference":[{"key":"BFgene200961_CR1","first-page":"267","volume":"52","author":"AG Engel","year":"1977","unstructured":"Engel AG, Lambert EH, Howard FM . Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiological correlations. Mayo Clin Proc 1977; 52: 267\u2013280.","journal-title":"Mayo Clin Proc"},{"key":"BFgene200961_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1172\/JCI0216086","volume":"110","author":"F Lin","year":"2002","unstructured":"Lin F, Kaminski HJ, Conti-Fine BM, Wang W, Richmonds C, Medof ME . Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J Clin Invest 2002; 110: 1269\u20131274.","journal-title":"J Clin Invest"},{"key":"BFgene200961_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","volume":"39","author":"K Shahashi","year":"1980","unstructured":"Shahashi K, Engel AG, Lambert EH, Howard FM . Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropath Exp Neurol 1980; 39: 160\u2013172.","journal-title":"J Neuropath Exp Neurol"},{"key":"BFgene200961_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","volume":"298","author":"DB Drachman","year":"1978","unstructured":"Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ . Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978; 298: 1116\u20131122.","journal-title":"N Engl J Med"},{"key":"BFgene200961_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00005072-197803000-00008","volume":"37","author":"K Sahashi","year":"1978","unstructured":"Sahashi K, Engel AG, Lindstrom JM, Lambert EH, Lennon VA . Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol 1978; 37: 212\u2013223.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFgene200961_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.147.4.973","volume":"147","author":"VA Lennon","year":"1978","unstructured":"Lennon VA, Seybold ME, Lindstrom J, Cochrane C, Ulevitch R . Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 1978; 147: 973\u2013983.","journal-title":"J Exp Med"},{"key":"BFgene200961_CR7","first-page":"2654","volume":"142","author":"G Biescker","year":"1989","unstructured":"Biescker G, Gomez CM . Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C5. Immunology 1989; 142: 2654\u20132659.","journal-title":"Immunology"},{"key":"BFgene200961_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0165-5728(96)00144-0","volume":"71","author":"SJ Piddlesden","year":"1996","unstructured":"Piddlesden SJ, Jiang S, Levin JL, Vincent A, Morgan BP . Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. J Neuroimmunol 1996; 71: 173\u2013177.","journal-title":"J Neuroimmunol"},{"key":"BFgene200961_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2249.2006.03198.x","volume":"146","author":"J Chamberlain-Banoub","year":"2006","unstructured":"Chamberlain-Banoub J, Neal JW, Mizuno M, Harris CL, Morgan BP . Complement membrane attack is required for end-plate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats. Clin Exp Immunol 2006; 146: 278\u2013286.","journal-title":"Clin Exp Immunol"},{"key":"BFgene200961_CR10","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.4049\/jimmunol.171.7.3847","volume":"171","author":"E T\u00fcz\u00fcn","year":"2003","unstructured":"T\u00fcz\u00fcn E, Scott BG, Goloszko E, Higgs S, Christadoss P . Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol 2003; 171: 3847\u20133854.","journal-title":"J Immunol"},{"key":"BFgene200961_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","volume":"201\u2013202","author":"RL Ruff","year":"2008","unstructured":"Ruff RL, Lennon VA . How myasthenia alters the safety factor for neuromuscular transmission. J Neuroimmunol 2008; 201\u2013202: 13\u201320.","journal-title":"J Neuroimmunol"},{"key":"BFgene200961_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","volume":"160","author":"ME Medof","year":"1984","unstructured":"Medof ME, Kinoshita T, Nussenzweig V . Inhibition of complement activation on the surface of cells after incorporation of decay accelerating factor (DAF) into their membranes. J Exp Med 1984; 160: 1558\u20131578.","journal-title":"J Exp Med"},{"key":"BFgene200961_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","volume":"166","author":"T Fujita","year":"1987","unstructured":"Fujita T, Inoue T, Ogawa K, Iida K, Tamura N . The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med 1987; 166: 1221\u20131228.","journal-title":"J Exp Med"},{"key":"BFgene200961_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","volume":"189","author":"HJ Kaminski","year":"2004","unstructured":"Kaminski HJ, Li Z, Richmonds C, Lin F, Medof ME . Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis. Exp Neurol 2004; 189: 333\u2013342.","journal-title":"Exp Neurol"},{"key":"BFgene200961_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.expneurol.2006.06.003","volume":"202","author":"HJ Kaminski","year":"2006","unstructured":"Kaminski HJ, Kusner LL, Richmonds C, Medof ME, Lin F . Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia. Exp Neurol 2006; 202: 287\u2013293.","journal-title":"Exp Neurol"},{"key":"BFgene200961_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2249.2006.03205.x","volume":"146","author":"BP Morgan","year":"2006","unstructured":"Morgan BP, Chamberlain-Banoub J, Neal JW, Song W, Mizuno M, Harris CL . The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice. Clin Exp Immunol 2006; 146: 294\u2013302.","journal-title":"Clin Exp Immunol"},{"key":"BFgene200961_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","volume":"17","author":"JM Heckmann","year":"2007","unstructured":"Heckmann JM, Owen EP, Little F . Myasthenia gravis in South Africans: racial differences in clinical manifestations. Neuromuscul Disord 2007; 17: 929\u2013934.","journal-title":"Neuromuscul Disord"},{"key":"BFgene200961_CR18","first-page":"1136","volume":"31","author":"JH Lass","year":"1990","unstructured":"Lass JH, Walter EI, Burris TE, Grossniklaus HE, Roat MI, Skelnik DL et al. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 1990; 31: 1136\u20131148.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgene200961_CR19","doi-asserted-by":"publisher","first-page":"12062","DOI":"10.1073\/pnas.211257298","volume":"98","author":"JD Porter","year":"2001","unstructured":"Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR et al. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci USA 2001; 98: 12062\u201312067.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene200961_CR20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4049\/jimmunol.144.2.740","volume":"144","author":"TW Post","year":"1990","unstructured":"Post TW, Arce MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM . Structure of the gene for human complement protein decay accelerating factor. J Immunol 1990; 144: 740\u2013744.","journal-title":"J Immunol"},{"key":"BFgene200961_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ygeno.2006.01.006","volume":"88","author":"F Osuka","year":"2006","unstructured":"Osuka F, Endo Y, Higuchi M, Suzuki H, Shio Y, Fujiu K et al. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor. Genomics 2006; 88: 316\u2013322.","journal-title":"Genomics"},{"key":"BFgene200961_CR22","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4049\/jimmunol.149.9.2906","volume":"149","author":"KE Coyne","year":"1992","unstructured":"Coyne KE, Hall SE, Thompson ES, Arce MA, Kinoshita T, Fuijita T et al. Mapping epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 1992; 149: 2906\u20132913.","journal-title":"J Immunol"},{"key":"BFgene200961_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-2567.2000.00086.x","volume":"101","author":"WG Brodbeck","year":"2000","unstructured":"Brodbeck WG, Kuttner-Kondo L, Mold C, Medof ME . Structure\/function studies of human decay-accelerating factor. Immunology 2000; 101: 104\u2013111.","journal-title":"Immunology"},{"key":"BFgene200961_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/325545a0","volume":"325","author":"IW Caras","year":"1987","unstructured":"Caras IW, Davitz MA, Rhee L, Davitz MA, Rhee L, Weddell G et al. Cloning of decay accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987; 325: 545\u2013548.","journal-title":"Nature"},{"key":"BFgene200961_CR25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0021-9258(17)35308-5","volume":"266","author":"P Moran","year":"1991","unstructured":"Moran P, Raab H, Kohr WJ, Caras IW . Glycophospholipid membrane anchor attachment. Molecular analysis of the cleavage\/attachment site. J Biol Chem 1991; 266: 1250\u20131257.","journal-title":"J Biol Chem"},{"key":"BFgene200961_CR26","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1073\/pnas.88.11.4675","volume":"88","author":"UK Ewulonu","year":"1991","unstructured":"Ewulonu UK, Ravi L, Medof ME . Characterization of the decay-accelerating factor gene promoter region. Proc Natl Acad Sci USA 1991; 88: 4675\u20134679.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene200961_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4049\/jimmunol.150.1.151","volume":"150","author":"DJ Thomas","year":"1993","unstructured":"Thomas DJ, Lublin DM . Identification of 5\u2032-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 1993; 150: 151\u2013160.","journal-title":"J Immunol"},{"key":"BFgene200961_CR28","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.4049\/jimmunol.177.6.3837","volume":"177","author":"DM Cauvi","year":"2006","unstructured":"Cauvi DM, Cauvi G, Pollard KM . Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1. J Immunol 2006; 177: 3837\u20133847.","journal-title":"J Immunol"},{"key":"BFgene200961_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00109-004-0603-7","volume":"83","author":"JC Knight","year":"2005","unstructured":"Knight JC . Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005; 83: 97\u2013109.","journal-title":"J Mol Med"},{"key":"BFgene200961_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1196\/annals.1405.037","volume":"1132","author":"J Soltys","year":"2008","unstructured":"Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner LL . Extraocular muscle susceptibility to myasthenia gravis. Unique immunological environment? Ann N Y Acad Sci 2008; 1132: 220\u2013224.","journal-title":"Ann N Y Acad Sci"},{"key":"BFgene200961_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.1066355","volume":"295","author":"AH Brivanlou","year":"2002","unstructured":"Brivanlou AH, Darnell Jr JE . Signal transduction and the control of gene expression. Science 2002; 295: 813\u2013818.","journal-title":"Science"},{"key":"BFgene200961_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0092-8674(89)90606-5","volume":"59","author":"AJ Courey","year":"1989","unstructured":"Courey AJ, Holtzman DA, Jackson SP, Tijan R . Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 1989; 59: 827\u2013836.","journal-title":"Cell"},{"key":"BFgene200961_CR33","doi-asserted-by":"crossref","first-page":"24892","DOI":"10.1016\/S0021-9258(19)74549-9","volume":"268","author":"YR Boisclair","year":"1993","unstructured":"Boisclair YR, Brown AL, Casola S, Rechler MM . Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J Biol Chem 1993; 268: 24892\u201324901.","journal-title":"J Biol Chem"},{"key":"BFgene200961_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/nar\/22.4.669","volume":"22","author":"MR Dusing","year":"1994","unstructured":"Dusing MR, Wiginton DA . Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter. Nucleic Acids Res 1994; 22: 669\u2013677.","journal-title":"Nucleic Acids Res"},{"key":"BFgene200961_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1152\/physiolgenomics.00163.2003","volume":"16","author":"T Pastinen","year":"2003","unstructured":"Pastinen T, Slavek R, Gurd S, Sammak A, Ge B, Lepage P et al. A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 2003; 16: 184\u2013193.","journal-title":"Physiol Genomics"},{"key":"BFgene200961_CR36","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1128\/MCB.20.24.9113-9119.2000","volume":"20","author":"IA Udalvo","year":"2000","unstructured":"Udalvo IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B et al. Functional consequences of a polymorphism affecting NF-\u03baB p50\u2013p50 binding to the TNF promoter region. Mol Cell Biol 2000; 20: 9113\u20139119.","journal-title":"Mol Cell Biol"},{"key":"BFgene200961_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20040863","volume":"201","author":"J Liu","year":"2005","unstructured":"Liu J, Miwa T, Hilliard B, Chen Y, Lambris JD, Wells AD et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 2005; 201: 567\u2013577.","journal-title":"J Exp Med"},{"key":"BFgene200961_CR38","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.20041967","volume":"201","author":"PS Heeger","year":"2005","unstructured":"Heeger PS, Lalli PN, Lin F, Valujskikh A, Lui J, Muqim N et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201: 1523\u20131530.","journal-title":"J Exp Med"},{"key":"BFgene200961_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.21536","volume":"65","author":"J Soltys","year":"2009","unstructured":"Soltys J, Kusner L, Young A, Richmonds C, Hatala D, Gong B et al. Novel complement inhibitor limits severity of experimental myasthenia gravis. Ann Neurol 2009; 65: 67\u201375.","journal-title":"Ann Neurol"},{"key":"BFgene200961_CR40","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1073\/pnas.80.16.5066","volume":"80","author":"A Nicholson-Weller","year":"1983","unstructured":"Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF . Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 1983; 80: 5066\u20135070.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene200961_CR41","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1073\/pnas.80.17.5430","volume":"80","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, Schreiber RD, Muller-Eberhard HJ . Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 1983; 80: 5430\u20135434.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene200961_CR42","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V84.4.1276.1276","volume":"84","author":"DM Lublin","year":"1994","unstructured":"Lublin DM, Mallinson G, Poole J, Reid ME, Thompson ES, Ferdman BR et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994; 84: 1276\u20131282.","journal-title":"Blood"},{"key":"BFgene200961_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2156-7-22","volume":"7","author":"H Taniguchi","year":"2006","unstructured":"Taniguchi H, Lowe CE, Cooper JD, Smyth D, Bailey R et al. Discovery, linkage disequilibrium and association analyses of polymorphisms of the immune complement inhibitor, decay-accelerating factor gene (DAF\/CD55) in type I diabetes. BMC Genetics 2006; 7: 22\u201331.","journal-title":"BMC Genetics"},{"key":"BFgene200961_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-2567.2006.02467.x","volume":"119","author":"SE Christmas","year":"2006","unstructured":"Christmas SE, de la Mata Espinosa CT, Halliday D, Buxton CA, Cummerson A, Johnson PM . Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes. Immunology 2006; 119: 522\u2013528.","journal-title":"Immunology"},{"key":"BFgene200961_CR45","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2353\/ajpath.2007.060601","volume":"170","author":"T Miwa","year":"2007","unstructured":"Miwa T, Maldonado MA, Zhou L, Yamada K, Gilkeson GS, Eisenberg RA et al. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL\/lpr mice via both complement-dependent and -independent mechanisms. Am J Path 2007; 170: 1258\u20131266.","journal-title":"Am J Path"},{"key":"BFgene200961_CR46","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","volume":"179","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Gong B, Lin F, Rother RP, Medof ME, Kaminski HJ . Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis. J Immunol 2007; 179: 8562\u20138567.","journal-title":"J Immunol"},{"key":"BFgene200961_CR47","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Soci\u00e9 G, Muus P et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355: 1233\u20131243.","journal-title":"N Engl J Med"},{"key":"BFgene200961_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nm836","volume":"9","author":"M Basta","year":"2003","unstructured":"Basta M, Van Goor F, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L et al. F(ab)\u20322-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003; 9: 431\u2013438.","journal-title":"Nat Med"},{"key":"BFgene200961_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFgene200961_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2144\/05391RV01","volume":"39","author":"ML Wong","year":"2005","unstructured":"Wong ML, Medrano JF . Real-time PCR for mRNA quantification. Biotechniques 2005; 39: 75\u201385.","journal-title":"Biotechniques"},{"key":"BFgene200961_CR51","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/nprot.2006.236","volume":"1","author":"T Nolan","year":"2006","unstructured":"Nolan T, Hands RE, Bustin SA . Quantification of mRNA using real-time RT-PCR. Nat Protoc 2006; 1: 1559\u20131582.","journal-title":"Nat Protoc"},{"key":"BFgene200961_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0008-8749(03)00127-8","volume":"223","author":"A Iborra","year":"2003","unstructured":"Iborra A, Mayorga M, Llobet N, Martinez P . Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. Cell Immunol 2003; 223: 46\u201351.","journal-title":"Cell Immunol"},{"key":"BFgene200961_CR53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1074\/jbc.M407403200","volume":"280","author":"VR Holla","year":"2005","unstructured":"Holla VR, Wang D, Brown JR, Mann JR, Katkuri S, DuBois RN . Prostaglandin E2 regulates the complement inhibitor CD55\/decay-accelerating factor in colorectal cancer. J Biol Chem 2005; 280: 476\u2013483.","journal-title":"J Biol Chem"},{"issue":"Database issue","key":"BFgene200961_CR54","doi-asserted-by":"publisher","first-page":"D108","DOI":"10.1093\/nar\/gkj143","volume":"34","author":"V Matys","year":"2006","unstructured":"Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucl Acids Res 2006; 34 (Database issue): D108\u2013D110.","journal-title":"Nucl Acids Res"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gene200961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gene200961","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gene200961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:39:58Z","timestamp":1685093998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene200961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFgene200961"],"URL":"https:\/\/doi.org\/10.1038\/gene.2009.61","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,13]]}}}